BCRX Jan 2025 25.000 put
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
At close: 01:11PM EDT
| Previous Close | 12.78 |
| Open | N/A |
| Bid | 10.00 |
| Ask | 15.00 |
| Strike | 25.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 12.78 - 12.78 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 2 |
Simply Wall St.BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Is Expected To Breakeven In The Near Future
BioCryst Pharmaceuticals, Inc. ( NASDAQ:BCRX ) is possibly approaching a major achievement in its business, so we would...
GuruFocus.comInsider Buying: Chief R&D Officer Helen Thackray Acquires 30,000 Shares of BioCryst ...
Helen Thackray, Chief Research & Development Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 30,000 shares of the company on May 14, 2024.
GuruFocus.comDirector Steven Galson Acquires 21,940 Shares of BioCryst Pharmaceuticals Inc (BCRX)
On May 13, 2024, Steven Galson, a Director at BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 21,940 shares of the company, as reported in a recent SEC Filing.
© 2024 Yahoo. All rights reserved.